A novel chemical-defined medium with bFGF and N2B27 supplements supports undifferentiated growth in human embryonic stem cells.
about
Analysis of gene expression profiles in HeLa cells in response to overexpression or siRNA-mediated depletion of NASPCharacterization of integrin engagement during defined human embryonic stem cell cultureDeveloping defined culture systems for human pluripotent stem cellsBiological Effects of Culture Substrates on Human Pluripotent Stem Cells.Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neuronsEfficient feeder-free episomal reprogramming with small moleculesLaminin E8 fragments support efficient adhesion and expansion of dissociated human pluripotent stem cells.A thermoresponsive and chemically defined hydrogel for long-term culture of human embryonic stem cells.A large-scale proteomic analysis of human embryonic stem cellsXeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them.High-content screening of feeder-free human embryonic stem cells to identify pro-survival small molecules.Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells.Differentiation of human induced pluripotent stem cells into a keratinocyte lineageGenerating cartilage repair from pluripotent stem cells.Characterization of embryonic stem-like cells derived from HEK293T cells through miR302/367 expression and their potentiality to differentiate into germ-like cells.Small molecule-assisted, line-independent maintenance of human pluripotent stem cells in defined conditionsLentivirus-mediated reprogramming of somatic cells in the absence of transgenic transcription factors.Induction of pluripotent stem cells from a cynomolgus monkey using a polycistronic simian immunodeficiency virus-based vector, differentiation toward functional cardiomyocytes, and generation of stably expressing reporter lines.Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: progress and challengesAn optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells.Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings: a view in 2013Design of a Vitronectin-Based Recombinant Protein as a Defined Substrate for Differentiation of Human Pluripotent Stem Cells into Hepatocyte-Like CellsComparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue.Stimulation of ovarian stem cells by follicle stimulating hormone and basic fibroblast growth factor during cortical tissue culture.Challenges and approaches to the culture of pluripotent human embryonic stem cells.Scalable human ES culture for therapeutic use: propagation, differentiation, genetic modification and regulatory issues.Establishment of bovine embryonic stem cells after knockdown of CDX2.Characterization of human skin-derived mesenchymal stem cell proliferation rate in different growth conditions.Comparison of a xeno-free and serum-free culture system for human embryonic stem cells with conventional culture systems.Dosage and cell line dependent inhibitory effect of bFGF supplement in human pluripotent stem cell culture on inactivated human mesenchymal stem cells.Estrogen and thyroid cancer is a stem affair: A preliminary study.Facile engineering of xeno-free microcarriers for the scalable cultivation of human pluripotent stem cells in stirred suspensionCardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.Rapid conversion of human ESCs into mouse ESC-like pluripotent state by optimizing culture conditions.Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) blocks differentiation and maintains the expression of pluripotency markers in human embryonic stem cells.Engineered polymer-media interfaces for the long-term self-renewal of human embryonic stem cells.Involvement of neuropeptide Y and its Y1 and Y5 receptors in maintaining self-renewal and proliferation of human embryonic stem cells.Extrinsic factors promoting in vitro differentiation of insulin-secreting cells from human adipose tissue-derived mesenchymal stem cells.Long-Term Culture of Japanese Human Embryonic Stem Cells in Feeder-Free Conditions.A reproducible and versatile system for the dynamic expansion of human pluripotent stem cells in suspension.
P2860
Q21245543-75603C03-996B-4162-94FC-C9DF737DC84FQ24319775-1613DF52-3EC3-4180-B7FE-F1C07A5B04F6Q27021126-AC6E6D72-73F7-4E5F-9F5D-13827B11E44AQ28077563-0A9887BA-856C-45D6-847F-BD0AD91FF6B7Q28476194-72079079-FB1C-42E9-B0A2-77A1F11CD3DBQ28742307-8838363E-B137-4ED7-BCEF-1C1A7AEE8B97Q30531074-8A9D49C6-F9AF-4722-9F97-44AAFA72C034Q30533944-42CB145A-FFFC-4ECC-ADCE-7F08AD4D985BQ33312530-C4619A72-03E7-455C-AF47-B1F4EEAB29FCQ33481637-3753833D-DD8F-4C91-A87E-FF5F3F24A981Q33696424-4775EBD9-FD8A-435D-9F62-E180FDEE6000Q33794176-6E60ED7E-28BC-4EF4-A13D-71CCEEC0B3ACQ33896006-5588428C-3C6B-470B-BA92-3E8710F237CCQ34009228-C3CDB793-96ED-4F65-ADB7-3004FBEBF461Q34150851-4A91AEB9-A533-41C3-BF48-8D4C70F56CF7Q34364345-CAF11764-1AAF-468A-A698-BC1A327C0BD6Q34383023-312F125C-E7E1-4B23-8ED2-1A9C82F7396BQ34775239-FA70FE6A-E5D8-4870-907C-2302CEB0637EQ35033727-D896E961-B77C-4D72-98E8-D85ACD08DC3DQ35180525-6D2B8637-81C5-490B-B85F-160D6D0E4936Q35620068-E4A2E4D6-C6DA-47A5-891C-94FEF54C3DCFQ35755765-1392CC8E-D824-4CE5-924C-CB94A6A98528Q36138509-D328CF4F-F28A-48C6-931A-F1E70290C384Q36793942-1E79CB92-9869-4417-A2C9-F78FBF24FC35Q36825868-041FCE42-A550-48F8-8236-C4A24EE8538AQ37001385-2E19689D-5644-4F5E-9CC3-F2620746552EQ37019314-7CBC9768-280C-49D5-893A-3913E9225524Q37120340-8517CFFA-74D6-4ECD-9093-20BDB3EAC57EQ37139873-32F92E2C-DD1C-48AE-A47D-E7ED381E72EFQ37490818-BD37F592-10D0-40E6-9A3C-CB9368C5D969Q37568455-3488EC63-7EB3-4C0A-ACCB-32484F1C7C15Q37587951-A9041366-4A5B-4B5D-A794-ED6305543C4EQ37832530-81AC7ED9-DA0F-41E6-9DAD-03A50EEA6006Q39407306-E82CACA2-13D9-4471-9DF4-3823F2416EC7Q39648017-E0B11B32-CF39-4D62-B204-D5B5375D0B6FQ41885527-AA2C5368-F42C-4C7C-AB86-87EF3BDE64F3Q42714859-272D5BEB-A091-44D5-8191-A715921D7579Q46794499-83D5F932-C752-4FAC-A535-50F6A13E3CB3Q47718074-22BC3114-1969-4157-BB58-2F49B6678ED5Q48109644-F6BB33F9-213A-4D93-8AC3-352A5335AEF6
P2860
A novel chemical-defined medium with bFGF and N2B27 supplements supports undifferentiated growth in human embryonic stem cells.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A novel chemical-defined mediu ...... in human embryonic stem cells.
@ast
A novel chemical-defined mediu ...... in human embryonic stem cells.
@en
A novel chemical-defined mediu ...... in human embryonic stem cells.
@nl
type
label
A novel chemical-defined mediu ...... in human embryonic stem cells.
@ast
A novel chemical-defined mediu ...... in human embryonic stem cells.
@en
A novel chemical-defined mediu ...... in human embryonic stem cells.
@nl
prefLabel
A novel chemical-defined mediu ...... in human embryonic stem cells.
@ast
A novel chemical-defined mediu ...... in human embryonic stem cells.
@en
A novel chemical-defined mediu ...... in human embryonic stem cells.
@nl
P2093
P1476
A novel chemical-defined mediu ...... in human embryonic stem cells.
@en
P2093
Guangwen Wang
Hong Zhang
Hongkui Deng
Mingxiao Ding
Siming Jiang
Tianxin Yu
Yanxia Liu
P304
P356
10.1016/J.BBRC.2006.05.086
P407
P577
2006-05-24T00:00:00Z